Maravai LifeSciences

We seek to acquire established, successful and pioneering businesses with the following characteristics:

  • Operations focused primarily in life sciences research and in vitro diagnostics products markets
  • Leadership positions driven by proprietary products in their principal operating segments
  • Clear revenue growth opportunities along with positive operating earnings and cash flows

Companies in our current portfolio are:

Vector_Logo_280x124pxl_96dpi.jpg
Cygnus_Logo_280x124pxl_96dpi.jpg
TriLink_Logo_280x124pxl_96dpi.jpg
Glen_Logo_280x124pxl_96dpi.jpg
 

Protein labeling and detection

Catalyzing the miracle of tumor pathology

Vector_Logo_280x124pxl_96dpi.jpg

Vector Laboratories is a leading developer and provider of reagents used by researchers in protein labeling and detection.

  • Over 600 products used in a broad range of research fields, including cancer, neurobiology, infectious diseases and diabetes
  • Cited in over 70,000 publications since 2010
  • Highly regarded for product quality and customer service in the research community since its inception in 1976
  • Headquarters located in Burlingame, California


Impurity detection and identification

Catalyzing the miracle of biotherapeutics

Cygnus_Logo_280x124pxl_96dpi.jpg

Cygnus Technologies is the world leader in providing products for detecting impurities and contaminants that must be screened and detected during biotherapeutics process development and quality control.

  • Develops and manufactures a broad menu of assay kits and immunoassay reagents for the detection of host cell proteins
  • Trusted by leading biotech and pharma customers around the globe
  • Introduced its first products in 1998 and has continually grown its reputation for unsurpassed quality
  • Headquarters located in Southport, North Carolina

Oligonucleotide synthesis & chemistry

Catalyzing the miracle of genomics

TriLink_Logo_280x124pxl.png

TriLink Biotechnologies is the leading provider of highly modified nucleic acids used by researchers and OEM partners in the fields of cellular and molecular biology.

  • Founded in 1996 with the goal of addressing the growing need for modified nucleic acids in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics
  • Specializes in the manufacture of modified nucleic acid products including custom oligonucleotides, mRNA, modified nucleoside triphosphates, CleanAmp™ PCR products, phosphoramidites and other small molecules
  • Headquarters located in San Diego, California

 
Glen_Logo_280x124pxl_96dpi.jpg

Glen Research offers a wide range of phosphoramidites and solid supports for the chemical synthesis, modification, labeling and purification of DNA and RNA oligonucleotides.

  • Founded in 1986, at the outset of the genomics revolution
  • Focuses on providing the highest quality reagents, backed by rigorous quality control and analysis for DNA and RNA research and production
  • Headquarters located in Sterling, Virginia